Protocol F1J-MC-HMEO duloxetine versus placebo in the treatment of chronic low back pain
Phase of Trial: Phase III
Latest Information Update: 05 Jan 2010
At a glance
- Drugs Duloxetine (Primary)
- Indications Back pain
- Focus Registrational; Therapeutic Use
- Sponsors Eli Lilly
- 01 Sep 2009 Results were published in the European Journal of Neurology.
- 01 Sep 2009 Primary endpoint 'Pain intensity' has not been met.
- 25 Aug 2008 Results presented at the 2008 EFNS, according to an Eli Lilly media release. Actual patient number is 404.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History